GlassScriptPhysician profile
John F Koval
NPI 1962405597
$814.84
in general payments reported to CMS, 2019-2025
12 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2023: $236 · 2024: $17.46 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $236.16 | 2023 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $166.07 | 2021 | |
| Heartflow, INC. | $155.45 | 2025 | |
| Boston Scientific Corporation | $86.81 | 2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.97 | 2025 | Lifevest |
| Pfizer INC. | $26.46 | 2021 | |
| Amgen INC. | $25.15 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.59 | 2021 | |
| Mirati Therapeutics, INC. | $17.46 | 2024 | Krazati |
| Novo Nordisk INC | $17.41 | 2021 | |
| Amarin Pharma, INC. | $17.33 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Koval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.